Two previous large genetic linkage studies in the US population have implicated an area in chromosome 1p to contain a susceptibility gene for alcohol dependence. The 1-LOD support interval of the linkage signal spans about 30 cM and contains 430 000 000 DNA base pairs (bp) and 700 predicted genes. In order to reduce the size of the candidate area and potentially identify novel candidate genes within this region, we fine-mapped this area using closely spaced short tandem repeat (STR) markers and the transmission disequilibrium test (TDT) in small nuclear families. The subjects were 87 European-American families including one or more alcohol-dependent offspring (93 children and 174 parents). The initial marker set consisted of 30 STR markers, spanning the Marshfield map interval between 101.48 and 130.73 cM. Using the TDTPHASE program, we identified three markers in the distal part of this region (125-126 cM), which showed evidence of transmission disequilibrium. On the basis of this result, an additional 12 STR markers were genotyped in this region; some of these markers provided additional evidence for linkage disequilibrium. The strongest evidence for transmission disequilibrium was obtained at the marker D1S406 (P¼0.005, 126.16 cM), with supporting evidence from three neighboring STR markers D1S424 (126.16 cM, P¼0.01), D1S2804 (126.16 cM, P¼0.04), and D1S2776 (126.16 cM, P¼0.02), which are all located within a o350 000 bp interval. These findings suggest that a gene (or genes) causing susceptibility to alcohol dependence resides near location 126.16 cM on chromosome 1. In addition, these results provide independent confirmation of the linkage finding regarding the identification of at least one gene in this region increasing the risk for alcohol dependence.
Introduction
Two large genomewide linkage scans by the Collaborative Study on the Genetics of Alcoholism (COGA) group have provided evidence supporting that a gene (or genes) increasing susceptibility to alcohol dependence resides on chromosome 1p. [1] [2] [3] [4] The COGA linkage study consisted of an initial sample of 225 alcohol-dependent sibpairs and a replication sample of 266 sibpairs drawn from extended pedigrees with a high density of alcohol dependence. The families were collected in the United States, and the subjects were largely European-American. Both the initial and the replication sample provided support for linkage between alcohol dependence and markers in chromosome 1p. The highest multipoint LOD score of 2.6 was obtained between markers D1S2614 (104.79 cM) and D1S1588 (125.51 cM) in chromosome 1. The 1-LOD support interval of this region spans approximately 30 cM, an extensive region that contains 430 000 000 base pairs (bp) and is predicted to harbor about 700 genes. Further evidence for the presence of a risk gene for alcoholism in this area was presented by Nurnberger et al. 5 They reanalyzed the COGA linkage data, allowing the affected phenotype to include not only alcohol dependence, but also depression, present either with or without comorbid alcohol dependence. This was justified because numerous twin and family studies have suggested that a significant portion of the liability for alcoholism and depression is shared. 6, 7 Furthermore, the two disorders commonly co-occur in the same individuals. [6] [7] [8] [9] Inclusion of individuals with depression in the affected category increased the support for linkage at the same area of chromosome 1p. A nonparametric LOD score of 4.66 was obtained at the same marker positions as compared to the phenotype of alcohol dependence only. 5 The resulting increment in support for linkage was primarily due to the inclusion of depressed women, who were relatives of alcoholic men. The highest percentages of the sharing of alleles identical-by-descent at the linked loci were not significantly changed (about 56-61%) as compared to the phenotype of alcohol dependence only. These results may be considered to support the hypothesis that the chromosome 1 locus (or loci) acts to increase the risk for both alcohol dependence and depression, potentially via a common etiologic pathway.
Linkage disequilibrium (LD) mapping has been advocated as a complementary or alternative method to genetic linkage mapping. LD methods have inherently higher statistical power and greater precision as compared to the genetic linkage methods. 10 The strategy of using genetic linkage in coarse genomic localization, followed by LD-fine mapping, has been used with success to identify risk genes for complex traits. For example, this strategy was recently used to identify two genes for schizophrenia. 11, 12 Although this approach is proving to be successful, many technical and population-related questions are still being debated and remain untested using empirical data. For example, it has been argued that singlenucleotide polymorphisms (SNPs) provide the optimal mapping tool because of their proposed higher potential to retain LD over longer genomic regions as compared to STR markers, although contrasting empirical evidence was presented in two recent studies. 13, 14 For simple Mendelian traits, linkage findings are frequently population-specific (indeed, many specific populations are known to have particular disease heritages). However, the extent to which complex-trait linkage findings can be generalized from the populations where they are identified to other populations is not known. Complex trait linkages may generalize more readily between populations, because of the likely involvement of common genes. An additional issue in the transition from linkage to linkage disequilibrium findings is that linkage samples, unlike association or TDT samples, are generally selected for high familial loading. Thus, samples whence linkage findings are derived may provide a different representation of risk alleles than population-based LD samples-specifically, they may be relatively enriched for high-l risk loci compared to the general population. Furthermore, linkage studies by different research groups in different populations commonly implicate nonoverlapping genomic areas. It is unclear whether this is due to differences in the importance of genetic factors in different populations, or poor sensitivity and resolution of the genetic linkage method and the tendency of this approach to miss or falsely identify genes. The majority of the studies that successfully followed up on earlier linkage findings using LD methods used the same population in both the linkage and LD fine-mapping phases of the gene-identification process. Following these arguments, searching for an LD in a patient sample in which linkage has not been explicitly demonstrated could be considered risky because of complex trait heterogeneity and random sample biases. On the other hand, if the risk gene is present in the study population, then LD-based methods should provide the best chances of detecting it. 10 The goal of this study was to narrow the previously identified chromosome 1p linkage region by using LD fine mapping to make possible the identification of a small number of positional candidate genes contributing to susceptibility for alcohol dependence. We hypothesized that we would identify LD signals in only one cluster of markers in a specific region. A sample of European-American small nuclear families was assembled for this purpose. We genotyped a set of STR markers, spanning the approximate 1-LOD support interval of the chromosome 1 alcohol dependence linkage region, and used the TDT to seek evidence for overtransmission of alleles from parents to their alcohol-dependent offspring. We found evidence for overtransmission in a set of closely spaced markers mapped to a o350 000 bp interval in the 126.16 cM region of chromosome 1. These results warrant cautious optimism that a gene contributing to the risk for alcoholism resides in this area of chromosome 1, and provide a good starting point for the efforts to identify such a gene. These results also suggest that following up on linkage findings using STR markers and family-based association tests may be a successful strategy in the identification of genes for complex diseases, even though the study involves samples not ascertained based on familial occurrence of the disease.
Materials and methods

Subjects
Small nuclear families consisting of both parents and their alcohol-dependent offspring were recruited at the University of Connecticut Health Center, Farmington or at the VA Connecticut Healthcare System, West Haven Campus. Of the 87 small nuclear families participating in this study, 81 families had one affected offspring and six had two affected siblings (total n¼267). Both parents were available for all families. All probands and their affected siblings met the criteria for a lifetime diagnosis of DSM-III-R or DSM-IV alcohol dependence. The diagnoses were made using the Structured Clinical Interview for DSM-III-R, the Structured Clinical Interview for DSM-IV 15 or the Schedule for Affective Disorders and Schizophrenia. 16 Individuals with a clinical diagnosis of a psychotic illness, such as schizophrenia or schizoaffective disorder, were excluded. All subjects were European-American. All subjects gave written informed consent, as approved by the local institutional review boards.
Genotyping DNA was extracted from whole-blood samples using standard methods. The initial set of markers were chosen from the Marshfield collection (http:// research.marshfieldclinic.org/genetics) to provide an average of 1 cM coverage of the 1-LOD support interval. Primer sequences were obtained from the National Center for Biotechnology Information (NCBI) database (http://www.ncbi.nlm.nih.gov/). The marker S1B was amplified with primers 5 0 GTTT-CTTTGGCAATGGTAAATCAGTGG3 0 and 5 0 TCATAT- 0 . Marker amplicons were divided into panels based on their fluorescent label and amplicon length to allow analysis of multiple markers in a single run. In addition, when possible, 2-5 STR markers were PCR-amplified in one multiplex reaction. Reactions were optimized by testing various PCR conditions, including different Mg 2 þ concentrations, polymerases, and cycling conditions. Several test runs were performed before the actual genotyping took place. Suboptimal PCR amplification, poor trace quality, or apparent loss of heterozygosity led to exclusion of several markers either at the testing phase or during the genotyping process. The initial set consisted of 30 STR markers, which are described in Figures 1, 2 . For the sake of clarity, these markers are termed the first-phase markers. PCR reactions were set up using a TECAN Genesis RSP 150 robot. We used an MJR-PTC 225 thermal cycler for PCR amplification. STR marker genotyping was done on an ABI3100 semi-automated sequencer. An additional 12 markers were genotyped in the distal area of the original region of interest, where the initial signal was detected for transmission disequilibrium. For the sake of clarity, these markers are termed the second-phase markers. These markers were obtained either from the Marshfield collection or are novel, identified from the genomic sequence based on our identification of likely repeat sequences using the RepeatFinder program (http://cbsu.tc.cornell.edu/webcomp.htm). Multiple repeat elements were identified in this region. Potentially polymorphic regions were amplified using PCR and analyzed on agarose gels to identify length variation. Regions that were found to be polymorphic were then amplified using fluorescent-labeled primers and analyzed as described above. Markers S1E, S1B, and S4B were identified in this manner. The STR marker data were scored and inspected for accuracy using the ABI Genotyper program. The data were scored twice by different investigators. The genotypes were stored in the Genomica DM database (Visualize, Inc.), which was also used to prepare output files for further analysis.
Data analysis
The Genomica DM pedigree check module and the Simwalk2 17 program were used to analyze the data for the presence of errors in Mendelian transmission. The programs Simwalk2 and GOLD were used to estimate and visualize intermarker LD using the nuclear family data. 17, 18 Markers were tested for transmission disequilibrium, using the TDTPHASE program of the UNPHASED software package (http://www.hgmp. mrc.ac.uk/). Analyses were done through the Genetic Linkage User Environment (GLUE) interface. Both GLUE and UNPHASED are available through the UK MRC Human Genome Mapping Project Resource Center's website (http://www.hgmp.mrc.ac.uk/). For the TDTPHASE analysis, we ran the analysis under the 'certain haplotypes' option, which implements the ETDT method for multiallelic markers and the algorithm developed by Dudbridge et al to avoid the potential bias introduced by uncertain phase. 19, 20 All analyses presented in this paper were done using the haplotype window size of one, unless otherwise stated. Option 'drop rare haplotypes' was used to restrict the analysis to the alleles with a frequency 43%. TDTPHASE seeks evidence of whether a certain allele or sets of alleles are overtransmitted. In other words, TDTPHASE analyzes the transmission data from multiple alleles simultaneously and the Pvalue is either reflective of transmission events of one allele or more than one allele. This is a biologically plausible model considering that LD between the disease allele and the marker may not be restricted to only one haplotype. This is particularly likely in the case of STR markers, which are more mutable than SNPs, and the disease allele may be present on more than one background. We have termed this markerspecific TDTPHASE estimate of the significance as the 'global P-value.' If the global P-value indicated that marker alleles (or a marker allele) were transmitted unequally, we then studied transmissions of individual alleles using the 'individual haplotypes' option of the TDTPHASE. This analysis compares the transmission of each individual allele against the other alleles, which are collapsed into one group. We have termed this estimate of significance as the 'allele-specific' P-value. All P-values presented in this paper refer to the global P-values, unless otherwise stated.
Order of the markers in the area of interest in chromosome 1
The STR markers were selected from the Marshfield collection and initially ordered according to the genetic coordinates. All genetic map positions presented in this paper refer to the Marshfield positions, unless otherwise indicated. We used additional information by the Golden Path genome browser at the University of Santa Cruz (http://www.genome.ucsc.edu/) and the deCODE genetic map 21 for further marker ordering and resolution of discrepancies between the maps. In addition, the marker order in the area surrounding D1S406 was resolved using information from two fine-mapping studies of this region. These studies focused on identification of the gene for Stargardt's disease, which is also located in this genomic region. 22, 23 Information from different sources were in agreement, with a few exceptions. We present the best estimate order of the markers in Figure 2 and Table 1 . The markers S1E, S1B, and S4B, which were identified in our laboratory, were ordered in relation to the other markers using the physical positions in the Golden Path.
Results
TDT for alcohol dependence
The TDTPHASE analysis of the first-phase markers showed evidence for transmission disequilibrium at the following loci: D1S224 (102.02 cM, P¼0.012), D1S465 (107.56 cM, P¼0.043), D1S406 (126.16 cM, P¼0.005), and D1S415 (125.51 cM, P¼0.038). Finding the lowest P-value at D1S406 was of greatest interest, because this locus was adjacent to a marker D1S415, Figure 2 Marshfield locations of the first-and secondphase markers. The left vertical bar refers to the approximate position of the first-phase markers in relation to chromosome 1. The right vertical bar refers to the approximate positions of the second-phase markers in relation to the first-phase markers. Marker names are followed by the location in the Marshfield map (cM). *TDTPHASE global Pvalue o0.05, **Po0.01.
which also showed a significant TDTPHASE P-value. In addition, D1S2868, which maps to the same Marshfield position as D1S406, showed nominally suggestive evidence for transmission disequilibrium (P¼0.128) (and two of six common alleles at this locus showed trend level (0.05oPo0.1) over-or undertransmission in the allele-specific test). Furthermore, at each of these latter three marker loci (close to 125-126 cM), examination of the transmission of the individual alleles showed the presence of a relatively common allele (frequency of the transmitted allele 425%), which was transmitted unequally and was contributing most of the asymmetry in transmissions. Analysis of the second-phase markers mapped to this area revealed a positive TDTPHASE P-value for the three markers: D1S424 (126.16 cM, P¼0.010), D1S2776 (126.16 cM, P¼0.019), and D1S2804 (126.16 cM, P¼0.042). That is, the initial positive findings in this region were confirmed with a different set of markers. Thus, in this study, at least nominally significant transmission disequilibrium was observed for seven markers, including four firstphase markers and three second-phase markers. Four of these markers (from both phases of the study) clustered in a narrow genomic region of about 350 000 bp. Among the markers including and internal to the positive markers that define the limits of this newly identified region of interest, D1S424 and D1S2776, there are a total of six markers, according to our best estimate of map positions. Of the six markers located at the 126.16 cM region (including those that define the region), four give positive transmissiondisequilibrium results with the trait of alcohol dependence, and two give negative results. Examination of individual alleles at the four positive marker loci located at the position of 126.16 cM revealed the presence of at least one common allele that was overtransmitted to the affected offspring. This was most pronounced for the markers D1S406 and D1S2776, which both had a common allele with highly significant overtransmission to the affected offspring (T%465%, Po0.01, see Table 2 ). Of the remaining 36 markers, only three gave a nominally positive transmission disequilibrium result. Marker D1S415, which is located at the Marshfield position 125.51 cM, appears to be located more distally and outside of the area 125-126 cM based on the deCODE map 21 and Golden Path physical coordinates. These data are presented in Table 1 .
Increasing the TDTPHASE haplotype window size to two or three and analysis of the four positive markers at the position of 126.16 cM (D1S424, D1S2804, D1S406, and D1S2776) failed to detect the common haplotypes. Most haplotypes were rare (1-10%). These analyses did not result in more significant TDTPHASE P-values. Using a window size of two, a haplotype between D1S424 and D1S2804 with a frequency of 16% was detected, which showed 79% overtransmission (allele-specific TDTPHASE P¼0.003). The large number of haplotypes may reflect the relative sparsity of the map and the high number of alleles each individual marker had in this population.
LD in the area of interest in chromosome 1
Overall, few areas of strong marker-marker LD were observed in this large region. The highest D 0 (normalized LD) value of 0.66 was observed between S4B and D1S236. After genotyping the second-phase markers in the area of 125-128 cM, a cluster of eight markers including and internal to D1S188-D1S2849 were identified, within which the majority were in varying degrees of significant LD in relation to one another. All marker pairs between D1S424 and D1S2776 were in significant LD, with exceptions of the pairs D1S424-D1S406, D1S2804-D1S406, and D1S406-S1E. The significant D 0 values between the markers at the 126.16 cM location were relatively low, ranging from 0.19 to 0.48. Other smaller areas of significant LD were also observed both proximal and distal to this cluster. Visual demonstration of the LD relationships between the markers at the area where significance to the alcohol dependence trait was observed (via GOLD) is presented in Figure 1 .
Discussion
In this study, we used LD fine mapping to greatly narrow an area in chromosome 1, which had been implicated to contain a susceptibility gene for alcohol dependence. Besides narrowing the region, this study Marshfield refers to the position of the marker on the Marshfield map. UCSC refers to the physical position of the marker on the University of Santa Cruz's Golden Path genome browser. D1S1170 and D1S406 were ordered in relation to other markers based on the UCSC coordinates and based on the information presented in two previous fine-mapping studies. 20, 21 D1S2849 and D1S2868 were ordered based on the previous fine-mapping study of Allikmets.
20 P-value is the global TDTPHASE P-value.
provides independent replication for a gene (or genes) in the region influencing the trait. Two previous large genetic linkage studies in the US population by the COGA group had presented strong evidence for the presence of a gene predisposing to alcohol dependence in this area of chromosome 1. [1] [2] [3] [4] [5] We genotyped a set of closely spaced STR markers, encompassing the approximate 1-LOD support interval of the linkage region, in a collection of European-American nuclear families. The markers were tested for transmission disequilibrium using the TDTPHASE program. The main finding in this study was the identification of a tight cluster of four markers in the area of 126.16 cM, which showed evidence for transmission disequilibrium with the alcohol dependence trait. The strongest signal was obtained at the marker D1S406. This finding was supported by three neighboring STR markers with significant TDTPHASE P-values. These markers are located within an 350 000 bp interval and flanked by markers D1S1170 and D1S2849, which are located about o1 000 000 bp apart. Most of the markers in this area were in a low-degree, yet significant LD to one another (D 0 ¼0.19-0.48). Examination of individual alleles at the four positive marker loci revealed the presence of a common allele that was overtransmitted to the affected offspring. This was particularly pronounced for the markers D1S406 and D1S2776, which both had common alleles with highly significant overtransmission to the affected offspring (T%465%, Po0.01; see Table 2 ). Two markers, S1E and S1B, both within this region, did not show significant transmission disequilibrium. Such a finding is not entirely unexpected, considering that multiple studies have shown that physical distance is not necessarily in linear correlation with LD across short genomic segments. 24 In addition, we identified 22 alleles for the marker S1B in this limited population of 348 founder chromosomes. It is possible that a high mutation rate reflected in the high level of polymorphism causes an unpredictable LD pattern around this marker. Only limited empirical work has been published addressing LD between STR markers, or between SNP-STR pairs. It has been argued that STR markers provide an inferior mapping tool in comparison to SNPs, because the higher mutation rate at the STR loci would cause LD to fall off more rapidly than between SNPs. However, two recent studies that focused on estimating LD between various types of closely spaced markers suggested that, on average, LD is retained over longer segments between STR markers than between SNPs. 13, 14 We are aware of at least one previous study that used STR markers to narrow a linkage region. Kaplan et al 25 used LD methods in an attempt to fine map a reading disability locus on chromosome 6. LD was identified with several markers, but in that study, a final map localization of a risk locus was more ambiguous than in the present investigation. This might be attributable in part to use of a more heterogeneous clinical population studied by those investigators. We attempted to reduce genetic heterogeneity, discussed below, and also heterogeneity in LD (a situation that could result in different marker alleles in LD with the same disease-associated allele in different populations obscuring a TDT finding), by studying only European-Americans.
A caveat in the interpretation of this study is that a total of 42 multiallelic markers were tested for transmission disequilibrium. Many of the tests cannot be considered independent because of intermarker LD and the two-tiered genotyping strategy, and therefore a strict Bonferroni correction would clearly be overconservative; still, some correction for multiple testing may be warranted. However, given that this study followed up on a previous linkage finding, and that the evidence for transmission disequilibrium was obtained at several adjacent closely spaced markers, these findings warrant optimism that a gene increasing risk for alcohol dependence resides in the area of 126.16 cM of chromosome 1. TDT, unlike the casecontrol methods, is not biased by the presence of population stratification in the sample, and thus the results presented here should not be false positives on that basis, even though the subjects may have been descendants of different European subpopulations. The population for the COGA genetic linkage study was collected from the general US population, consisting largely of European-Americans (80%), but also African-Americans and Hispanics. Allelic heterogeneity at the disease locus, due to, for example, ethnic differences, decreases the power of LD-based methods. To minimize this potential, we restricted the study sample to the European-American population. Limited empirical research has addressed the effect of ethnicity and allelic heterogeneity at the disease locus Only those alleles with positive allele-specific P-values are included in the table. Numbers in parentheses after the marker name refer to the total number of alleles (frequency 43%). T and NT refer to the number of times the allele was transmitted and was not transmitted, respectively. FreqT refers to the frequency of the transmitted allele in the parental population of all transmitted alleles. T% refers to the transmission disequilibrium (ie 50% with no association). Allele P is the allele-specific TDTPHASE P-value.
on efforts to find genes for complex traits. It will be interesting to attempt to replicate this finding, not only in another European-American population, but also in populations that have undergone recent population bottlenecks or were recently admixed. Case-control studies of the markers in the associated cluster would also be of interest. Although the sample size in the present study was relatively small, LDbased methods, in general, are more sensitive than linkage (ie, they are able to detect smaller genetic effects), and a sample of 93 trios would give approximately 80% power to detect a common susceptibility variant (assumptions: 30% susceptibility allele frequency, D 0 ¼0.9, prevalence of alcoholism 14%, and marker allele frequency 40%, and relative risk for Aa¼4 and AA¼5). 26 These assumptions could be viewed as overly optimistic if applied to a random genomic location, but our study was based on the premise of following up on a previous linkage finding. Linkage, in general, is not powerful for finding genetic susceptibility factors unless the allele causes greater than a four-fold increment in risk for the disease, or unless the number of sibpairs is exorbitantly large. 10 Based on these calculations, we speculate that the genotype relative risk of the mapped risk locus is probably greater than four.
Several genes have been localized to the 126.16 cM region, including transcription factors, growth factorrelated proteins and genes with unknown function but known expression in the brain. Narrowing the region from 30 million to an area of o1 million base pairs will allow the use of SNP-based genotyping of candidate genes to test for an association between haplotypes and alcohol dependence. In this study, haplotype analysis was not feasible because the STRs were not linked tightly enough to allow identification of common haplotypes. It is possible that an average 1 cM spacing is not sufficient to detect LD in a wide interval. Indeed, our marker-marker LD analyses showed that many pairs of markers were not in significant LD with each other. Although the present results confirm that the marker spacing we chose was both practical and sufficient for detection of a robust LD signal, we cannot exclude the possibility that additional alcohol-dependence risk loci map between pairs of markers in this region. Our approach, as compared to the use of SNPs, may allow a similar narrowing with much less genotyping. However, the exhaustiveness of our LD scan cannot be known presently. Previous studies that used SNPs to narrow linkage regions for complex traits used much more closely spaced (but considerably less informative) markers. 11, 12 These findings suggest that a gene for alcoholism may reside near the 126.16 cM region of chromosome 1, in an area approximately demarcated by the markers D1S1170 and D1S2779. We believe that these data add meaningfully to the existing findings in the study of the molecular genetics of alcoholism. Many genes, such as certain alcohol dehydrogenases and aldehyde dehydrogenase, 27 neuropeptide Y, 28 and GABA-A receptor, 29 have already been implicated in genetic risk for alcoholism. To our knowledge, this is the second fine-mapping report focusing on the genetic background of alcoholism using a positional strategy. Porjesz et al. followed up on the earlier COGA linkage findings at chromosome 4 and identified a common haplotype at the GABA-A receptor gene, which was associated with brain EEG variation, an endophenotype for risk for alcoholism.
Furthermore, the results presented in this paper suggest that fine mapping using STR markers and following up on the previous linkage findings in an independent, but ethnically similar population may be a feasible strategy to identify genetic factors for complex diseases. These results provide a starting point for more detailed LD analysis of the 126.16 cM genomic region, which may eventually allow identification of a gene for alcohol dependence in this region. Identification of such a gene would be of major importance for understanding the background of this common, debilitating and costly disorder. In addition, the gene predisposing to alcoholism at this locus could also increase the risk for depression. 5 Identification of the gene might provide the molecular explanation for the clinical observation of high comorbidity between the two disorders. This may help us to understand better the etiology of these disorders, thereby facilitating the development of more efficacious prevention and treatment strategies.
